MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Smith & Nephew PLC ADR

Закрыт

36.31 1.57

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

36.12

Макс.

36.35

Ключевые показатели

By Trading Economics

Доход

100M

296M

Продажи

4.7M

3B

P/E

Средняя по отрасли

31.438

36.442

Дивидендная доходность

2.16

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

6.5M

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+3.43% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.16%

3.00%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.9B

15B

Предыдущая цена открытия

34.74

Предыдущая цена закрытия

36.31

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

17 окт. 2025 г., 18:13 UTC

Главные движущие силы рынка

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 окт. 2025 г., 17:05 UTC

Главные движущие силы рынка

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 окт. 2025 г., 15:03 UTC

Главные движущие силы рынка

Obook Shares Sink Following Public Debut

17 окт. 2025 г., 14:41 UTC

Главные движущие силы рынка

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 окт. 2025 г., 23:25 UTC

Приобретения, слияния, поглощения

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 окт. 2025 г., 22:15 UTC

Обсуждения рынка

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 окт. 2025 г., 21:15 UTC

Обсуждения рынка

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 окт. 2025 г., 21:07 UTC

Обсуждения рынка

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 окт. 2025 г., 21:07 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

17 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

17 окт. 2025 г., 20:34 UTC

Обсуждения рынка

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 окт. 2025 г., 20:27 UTC

Обсуждения рынка

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 окт. 2025 г., 19:46 UTC

Обсуждения рынка

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 окт. 2025 г., 19:45 UTC

Обсуждения рынка

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 окт. 2025 г., 18:45 UTC

Обсуждения рынка

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 окт. 2025 г., 17:51 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

17 окт. 2025 г., 17:51 UTC

Обсуждения рынка

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 окт. 2025 г., 17:44 UTC

Обсуждения рынка

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 окт. 2025 г., 17:35 UTC

Обсуждения рынка

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 окт. 2025 г., 16:20 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

17 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

17 окт. 2025 г., 16:14 UTC

Обсуждения рынка

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 окт. 2025 г., 16:04 UTC

Обсуждения рынка

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 окт. 2025 г., 15:58 UTC

Обсуждения рынка

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 окт. 2025 г., 15:56 UTC

Отчет

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 окт. 2025 г., 15:43 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

17 окт. 2025 г., 15:43 UTC

Обсуждения рынка

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 окт. 2025 г., 14:58 UTC

Обсуждения рынка

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 окт. 2025 г., 14:41 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

17 окт. 2025 г., 14:35 UTC

Обсуждения рынка
Отчет

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

3.43% рост

Прогноз на 12 месяцев

Средняя 37.04 USD  3.43%

Максимум 40 USD

Минимум 34.65 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

4 ratings

1

Покупка

3

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat